Literature DB >> 27843344

The Danish National Database for Obstructive Sleep Apnea.

Poul Jørgen Jennum1, Preben Larsen2, Charlotte Cerqueira3, Thor Schmidt4, Philip Tønnesen1.   

Abstract

AIM: The aim of the Danish National Database for Obstructive Sleep Apnea (NDOSA) was to evaluate the clinical quality (diagnostic, treatment, and management) for obstructive sleep apnea and obesity hypoventilation syndrome in Denmark using a real-time national database reporting to the Danish National Patient Registry. STUDY POPULATION: All patients diagnosed with obstructive sleep apnea or obesity hypoventilation syndrome at public and private in- and out-hospital departments in Denmark were included. MAIN VARIABLES: The NDOSA contains information about baseline characteristics, comorbidity, diagnostic procedures conducted, treatment (continuous positive airway pressure and similar treatments, surgery, mandibular advancement devices, etc) complications, and treatment status. DESCRIPTIVE DATA: Yearly report with indicators for diagnostic procedures, treatment, and follow-up comparing different departments was involved in the management of sleep apnea in Denmark for the purpose of quality improvement.
CONCLUSION: The NDOSA has proven to be a real-time national database using diagnostic and treatment procedures reported to the Danish National Patient Registry.

Entities:  

Keywords:  clinical registry; obesity hypoventilation syndrome; obstructive sleep apnea; quality of care

Year:  2016        PMID: 27843344      PMCID: PMC5098514          DOI: 10.2147/CLEP.S101969

Source DB:  PubMed          Journal:  Clin Epidemiol        ISSN: 1179-1349            Impact factor:   4.790


Introduction

Obstructive sleep apnea (OSA) and obesity hypoventilation syndrome (OHS) are severe sleep-related breathing disorders that in total affect >5% of the adult population. Furthermore, OSA also affects children. These disorders are associated with significant morbidities, mortality, and consequently significant societal burden.1–4 The Danish National Database for OSA (NDOSA) was initiated in 2009 for the monitoring of management of OSA, diagnostic and treatment procedures, and follow-up to create a nationwide database for quality monitoring and research. More than 50,000 children and adult patients are included in the Danish National Patient Registry. Since the start of quality database in 2009, ~8,000 new patients per year have been included in the NDOSA. During its first year of existence, the quality indicators have increased overall. Diagnostic modalities include polysomnography, partial polygraphy (cardio-respiratory monitoring), and oximetry. Treatment modalities include positive airway pressure (PAP) using all modalities: fixed pressure; auto-adjusted, bilevel, and adaptive PAP; surgical procedures; and other procedures.

Aim of database

The main aim of the NDOSA was to improve the quality of procedures and care for patients undergoing diagnosis and treatment procedures for OSA in Denmark. In addition, we included patients with a diagnosis of OHS – a more severe form of sleep-disordered breathing associated with severe overweight. By describing variation in clinical practice across the country, the aim was to stimulate quality improvement initiatives to standardize excellence in practice and thus improve outcomes. The NDOSA aims to monitor and support the implementation of evidence-based treatment and care for patients undergoing diagnostic and treatment procedures for sleep-disordered breathing.

Study population

The NDOSA includes data on all diagnostic procedures from all public and private hospital departments (eg, pulmonary, ear–nose–throat, neurologic) evaluating OSA in Denmark. All data including diagnostic and treatment procedures in the NDOSA are extracted from the Danish National Patient Registry. All Danes hold a unique personal identification number (Central Person Registry number), allowing accurate linkage between health registers and other nationwide administrative registers on an individual level. NDOSA is approved as a clinical quality database by the Danish Health Authority and hospitals and clinics are thus required to report details of all treated patients to the database. Patient consent is not required for entry of data in NDOSA, because according to Danish law, approved clinical quality databases are exempt from the requirement of obtaining patients’ consent to collect relevant data. Patient consent is therefore not required for entry of data in the Danish clinical registries.

Main variables

The variables recorded in the NDOSA are basic patient characteristics, comorbidity, indication for the procedure, the diagnostic tests (polysomnography, partial polygraphy, oximetry) and treatments (PAP and surgical or no treatment), pretreatment apnea severity, treatment compliance, effect of treatment (change in apnea severity, sleepiness), and waiting time. Registration in the NDOSA is mandatory for all procedures performed in public and private Danish hospitals. As the data registration is obligatory for some of the indicators, the completeness is 100%; however, for one indicator that is not obligatory, the completeness is 97%. The key outcome data are quality measures, morbidities, mortality, and use of health care (Table 1).
Table 1

Quality indicators for the Danish NDOSA

Indicator
1Diagnostic method: Which diagnostic method is used (polysomnography, partial polygraphy, oximetry)?
2Treatment with (fixed, continuous, bilevel, adaptive) positive airway pressure, surgery (eg, uvulopalatopharyngoplasty and adenotonsillectomy), oral devices, etc
3Treatment with (fixed, continuous, bilevel, adaptive) positive airway pressure
4Patients obtaining good (continuous, bilevel, adaptive) positive airway pressure compliance (defined as a number of patients with the use of positive pressure treatment >4 hours)
5Change in apnea severity index from the time of diagnosis to after treatment
6Change in patients symptoms from the time of diagnosis to after treatment
7Control visit of (fixed, continuous, bilevel, adaptive) positive airway pressure, number of patients at follow-up
8Control visit after surgical procedure
9Number of patients undergoing diagnostic procedure <4 weeks after primary referral to diagnostic department

Abbreviation: NDOSA, National Database for Obstructive Sleep Apnea.

Follow-up

Audit is essential for the maintenance of good clinical practice for sleep apnea. The reported results are critically evaluated at annual meetings with the aim of improving the database content. In the case of outlier results (positive as well as negative), local audit is planned, performed, and published in the final annual report. Periodic assessments of the quality indicators are published on a monthly basis in the regional information systems. Each department has access to their own results, both to ensure real-time registration and the opportunity to make usage of own results for the further development and quality assurance in the units, respectively. These results are of interest to clinicians in this area and a useful guide for health care administrative workers and managers to help allocate maximum value for the limited resources available. Based on the register data, it has been shown that the quality regarding diagnostic and treatment procedures as well as follow-up percentage has improved overall (Figure 1). For five indicators, an improvement was observed; for two indicators, a decrease was found; and two indicators were unchanged from 2012 to 2014. However, the mean increase was only 2.7% with a range from −10% to +8% in the actual values.
Figure 1

Results for key quality indicators for the Danish NDOSA from 2012 to 2014.

Abbreviations: AHI, apnea–hypopnea index; CPAP, continuous positive airway pressure; NDOSA, National Database for Obstructive Sleep Apnea; PSG, polysomnography.

Examples of research

Based on the available data from the National Patient Register/NDOSA combined with other national databases, a number of studies have been conducted. These studies suggest that OSA/OHS is associated with significant societal burden in terms of direct and indirect costs and consequently societal costs,1,2 as well as an increased morbidity and mortality in children3 and adults when compared with healthy controls.4

Administrative issues and funding

The NDOSA was started after a pretest period from 2007 to 2009 to develop data extraction from the National Patient Register. The main problem experienced has been to transform an administrative database to a medical longitudinal database. The first local initiative, by a group of medical doctors, was taken in 2007. In 2009, the NDOSA was a nationwide register. NDOSA is part of the Danish Clinical Registries – a national improvement program and thus funded by the Danish Regions.

Conclusion

The NDOSA is monitoring all procedures in patients with OSA and OHS in Denmark. It contains information about baseline characteristics, comorbidity, procedures conducted, complications, medical treatment, and follow-up data. Due to these data, we have obtained a national uniform monitoring of the diagnostic and treatment quality in this area.
  4 in total

1.  Health, social and economical consequences of sleep-disordered breathing: a controlled national study.

Authors:  Poul Jennum; Jakob Kjellberg
Journal:  Thorax       Date:  2011-01-02       Impact factor: 9.139

2.  Morbidity and mortality in children with obstructive sleep apnoea: a controlled national study.

Authors:  Poul Jennum; Rikke Ibsen; Jakob Kjellberg
Journal:  Thorax       Date:  2013-06-08       Impact factor: 9.139

3.  Morbidity prior to a diagnosis of sleep-disordered breathing: a controlled national study.

Authors:  Poul Jennum; Rikke Ibsen; Jakob Kjellberg
Journal:  J Clin Sleep Med       Date:  2013-02-01       Impact factor: 4.062

4.  Social consequences of sleep disordered breathing on patients and their partners: a controlled national study.

Authors:  Poul Jennum; Rikke Ibsen; Jakob Kjellberg
Journal:  Eur Respir J       Date:  2013-04-05       Impact factor: 16.671

  4 in total
  1 in total

1.  Long-term health outcomes in patients with Prader-Willi Syndrome: a nationwide cohort study in Denmark.

Authors:  E Hedgeman; S P Ulrichsen; S Carter; N C Kreher; K P Malobisky; M M Braun; J Fryzek; M S Olsen
Journal:  Int J Obes (Lond)       Date:  2017-06-21       Impact factor: 5.095

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.